Annual Shareholders Equity
$1.88 B
+$7.32 M+0.39%
31 December 2023
Summary:
CRISPR Therapeutics AG annual stockholders equity is currently $1.88 billion, with the most recent change of +$7.32 million (+0.39%) on 31 December 2023. During the last 3 years, it has risen by +$218.57 million (+13.13%). CRSP annual shareholders equity is now -21.53% below its all-time high of $2.40 billion, reached on 31 December 2021.CRSP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$1.94 B
-$41.29 M-2.08%
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly stockholders equity is currently $1.94 billion, with the most recent change of -$41.29 million (-2.08%) on 30 September 2024. Over the past year, it has increased by +$211.86 million (+12.26%). CRSP quarterly shareholders equity is now -25.51% below its all-time high of $2.60 billion, reached on 30 June 2021.CRSP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.4% | +12.3% |
| 3 y3 years | +13.1% | -22.8% |
| 5 y5 years | +380.1% | +227.7% |
CRSP Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -21.5% | +13.1% | -22.8% | +12.3% |
| 5 y | 5 years | -21.5% | +380.1% | -25.5% | +227.7% |
| alltime | all time | -21.5% | +6570.8% | -25.5% | +3204.4% |
CRISPR Therapeutics AG Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.94 B(-2.1%) |
| June 2024 | - | $1.98 B(-4.9%) |
| Mar 2024 | - | $2.08 B(+10.7%) |
| Dec 2023 | $1.88 B(+0.4%) | $1.88 B(+9.0%) |
| Sept 2023 | - | $1.73 B(-4.9%) |
| June 2023 | - | $1.82 B(-2.1%) |
| Mar 2023 | - | $1.85 B(-1.1%) |
| Dec 2022 | $1.88 B(-21.8%) | $1.88 B(-4.0%) |
| Sept 2022 | - | $1.95 B(-6.5%) |
| June 2022 | - | $2.09 B(-6.9%) |
| Mar 2022 | - | $2.24 B(-6.4%) |
| Dec 2021 | $2.40 B(+44.2%) | $2.40 B(-4.5%) |
| Sept 2021 | - | $2.51 B(-3.5%) |
| June 2021 | - | $2.60 B(+44.2%) |
| Mar 2021 | - | $1.81 B(+8.5%) |
| Dec 2020 | $1.66 B | $1.66 B(+23.9%) |
| Sept 2020 | - | $1.34 B(+47.5%) |
| June 2020 | - | $910.67 M(+2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $886.10 M(-5.7%) |
| Dec 2019 | $939.42 M(+139.5%) | $939.42 M(+58.7%) |
| Sept 2019 | - | $591.88 M(+61.0%) |
| June 2019 | - | $367.68 M(-3.2%) |
| Mar 2019 | - | $379.81 M(-3.2%) |
| Dec 2018 | $392.19 M(+108.8%) | $392.19 M(-6.0%) |
| Sept 2018 | - | $417.31 M(+57.4%) |
| June 2018 | - | $265.15 M(-8.7%) |
| Mar 2018 | - | $290.33 M(+54.6%) |
| Dec 2017 | $187.83 M(-19.3%) | $187.83 M(+5.0%) |
| Sept 2017 | - | $178.96 M(-9.5%) |
| June 2017 | - | $197.80 M(-8.1%) |
| Mar 2017 | - | $215.18 M(-7.6%) |
| Dec 2016 | $232.85 M(-900.2%) | $232.85 M(-472.7%) |
| Sept 2016 | - | -$62.48 M(-146.2%) |
| June 2016 | - | $135.34 M(-565.1%) |
| Dec 2015 | -$29.10 M(+308.8%) | -$29.10 M |
| Dec 2014 | -$7.12 M | - |
FAQ
- What is CRISPR Therapeutics AG annual stockholders equity?
- What is the all time high annual shareholders equity for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual shareholders equity year-on-year change?
- What is CRISPR Therapeutics AG quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly shareholders equity year-on-year change?
What is CRISPR Therapeutics AG annual stockholders equity?
The current annual shareholders equity of CRSP is $1.88 B
What is the all time high annual shareholders equity for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual stockholders equity is $2.40 B
What is CRISPR Therapeutics AG annual shareholders equity year-on-year change?
Over the past year, CRSP annual stockholders equity has changed by +$7.32 M (+0.39%)
What is CRISPR Therapeutics AG quarterly stockholders equity?
The current quarterly shareholders equity of CRSP is $1.94 B
What is the all time high quarterly shareholders equity for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly stockholders equity is $2.60 B
What is CRISPR Therapeutics AG quarterly shareholders equity year-on-year change?
Over the past year, CRSP quarterly stockholders equity has changed by +$211.86 M (+12.26%)